These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 22971995)
21. MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2. Tang H; Fan D; Lei CT; Ye C; Gao P; Chen S; Meng XF; Su H; Zhang C J Mol Med (Berl); 2016 Nov; 94(11):1297-1307. PubMed ID: 27488450 [TBL] [Abstract][Full Text] [Related]
22. Cyclophilin D promotes tubular cell damage and the development of interstitial fibrosis in the obstructed kidney. Hou W; Leong KG; Ozols E; Tesch GH; Nikolic-Paterson DJ; Ma FY Clin Exp Pharmacol Physiol; 2018 Mar; 45(3):250-260. PubMed ID: 29230844 [TBL] [Abstract][Full Text] [Related]
23. Fluorofenidone attenuates renal interstitial fibrosis in the rat model of obstructive nephropathy. Li BX; Tang YT; Wang W; Xie YY; Wang NS; Yuan QJ; Zhang FF; Peng ZZ; Hu GY; Tao LJ Mol Cell Biochem; 2011 Aug; 354(1-2):263-73. PubMed ID: 21594754 [TBL] [Abstract][Full Text] [Related]
31. Protease-activated receptor 2 does not contribute to renal inflammation or fibrosis in the obstructed kidney. Ma FY; Han Y; Ozols E; Chew P; Vesey DA; Gobe GC; Morais C; Lohman RJ; Suen JY; Johnson DW; Fairlie DP; Nikolic-Paterson DJ Nephrology (Carlton); 2019 Sep; 24(9):983-991. PubMed ID: 31314137 [TBL] [Abstract][Full Text] [Related]
32. Twist relates to tubular epithelial-mesenchymal transition and interstitial fibrogenesis in the obstructed kidney. Kida Y; Asahina K; Teraoka H; Gitelman I; Sato T J Histochem Cytochem; 2007 Jul; 55(7):661-73. PubMed ID: 17341474 [TBL] [Abstract][Full Text] [Related]
33. TRAP1 ameliorates renal tubulointerstitial fibrosis in mice with unilateral ureteral obstruction by protecting renal tubular epithelial cell mitochondria. Chen JF; Wu QS; Xie YX; Si BL; Yang PP; Wang WY; Hua Q; He Q FASEB J; 2017 Oct; 31(10):4503-4514. PubMed ID: 28710113 [TBL] [Abstract][Full Text] [Related]
35. FHL2 participates in renal interstitial fibrosis by altering the phenotype of renal tubular epithelial cells via regulating the β-catenin pathway. Zhou SG; Ma HJ; Guo ZY; Zhang W; Yang X Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2734-2741. PubMed ID: 29771425 [TBL] [Abstract][Full Text] [Related]
37. Early differential expression of oncostatin M in obstructive nephropathy. Elbjeirami WM; Truong LD; Tawil A; Wang W; Dawson S; Lan HY; Zhang P; Garcia GE; Wayne Smith C J Interferon Cytokine Res; 2010 Jul; 30(7):513-23. PubMed ID: 20626292 [TBL] [Abstract][Full Text] [Related]
38. Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis. Bozic M; Caus M; Rodrigues-Diez RR; Pedraza N; Ruiz-Ortega M; Garí E; Gallel P; Panadés MJ; Martinez A; Fernández E; Valdivielso JM Nat Commun; 2020 Apr; 11(1):1943. PubMed ID: 32327648 [TBL] [Abstract][Full Text] [Related]
39. Peroxiredoxin 1 inhibits the oxidative stress induced apoptosis in renal tubulointerstitial fibrosis. Mei W; Peng Z; Lu M; Liu C; Deng Z; Xiao Y; Liu J; He Y; Yuan Q; Yuan X; Tang D; Yang H; Tao L Nephrology (Carlton); 2015 Nov; 20(11):832-42. PubMed ID: 25989822 [TBL] [Abstract][Full Text] [Related]